Pacific Center For Financial Services Regeneron Pharmaceuticals, Inc. Transaction History

Pacific Center For Financial Services

  • $339 Million
  • Q3 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$1024.09 - $1201.76 $0 - $0
0 New
0 $0
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $0 - $0
0 New
0 $0
Q1 2024

May 20, 2024
BUY
$902.69 - $993.35 $0 - $0
0 New
0 $0
Q3 2023

Nov 15, 2023
BUY
$692.45 - $844.37 $0 - $0
0 New
0 $0
Q2 2023

Aug 09, 2023
BUY
$700.03 - $830.35 $0 - $0
0 New
0 $0
Q1 2023

May 16, 2023
BUY
$680.49 - $826.97 $0 - $0
0 New
0 $0

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Pacific Center For Financial Services Portfolio

Follow Pacific Center For Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Center For Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Center For Financial Services with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email